Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 1;595(15):5191-5207.
doi: 10.1113/JP274515. Epub 2017 Jun 26.

Coupling of excitation to Ca2+ release is modulated by dysferlin

Affiliations

Coupling of excitation to Ca2+ release is modulated by dysferlin

Valeriy Lukyanenko et al. J Physiol. .

Abstract

Key points: Dysferlin, the protein missing in limb girdle muscular dystrophy 2B and Miyoshi myopathy, concentrates in transverse tubules of skeletal muscle, where it stabilizes voltage-induced Ca2+ transients against loss after osmotic shock injury (OSI). Local expression of dysferlin in dysferlin-null myofibres increases transient amplitude to control levels and protects them from loss after OSI. Inhibitors of ryanodine receptors (RyR1) and L-type Ca2+ channels protect voltage-induced Ca2+ transients from loss; thus both proteins play a role in injury in dysferlin's absence. Effects of Ca2+ -free medium and S107, which inhibits SR Ca2+ leak, suggest the SR as the primary source of Ca2+ responsible for the loss of the Ca2+ transient upon injury. Ca2+ waves were induced by OSI and suppressed by exogenous dysferlin. We conclude that dysferlin prevents injury-induced SR Ca2+ leak.

Abstract: Dysferlin concentrates in the transverse tubules of skeletal muscle and stabilizes Ca2+ transients when muscle fibres are subjected to osmotic shock injury (OSI). We show here that voltage-induced Ca2+ transients elicited in dysferlin-null A/J myofibres were smaller than control A/WySnJ fibres. Regional expression of Venus-dysferlin chimeras in A/J fibres restored the full amplitude of the Ca2+ transients and protected against OSI. We also show that drugs that target ryanodine receptors (RyR1: dantrolene, tetracaine, S107) and L-type Ca2+ channels (LTCCs: nifedipine, verapamil, diltiazem) prevented the decrease in Ca2+ transients in A/J fibres following OSI. Diltiazem specifically increased transients by ∼20% in uninjured A/J fibres, restoring them to control values. The fact that both RyR1s and LTCCs were involved in OSI-induced damage suggests that damage is mediated by increased Ca2+ leak from the sarcoplasmic reticulum (SR) through the RyR1. Congruent with this, injured A/J fibres produced Ca2+ sparks and Ca2+ waves. S107 (a stabilizer of RyR1-FK506 binding protein coupling that reduces Ca2+ leak) or local expression of Venus-dysferlin prevented OSI-induced Ca2+ waves. Our data suggest that dysferlin modulates SR Ca2+ release in skeletal muscle, and that in its absence OSI causes increased RyR1-mediated Ca2+ leak from the SR into the cytoplasm.

Keywords: dysferlin; excitation-contraction coupling; skeletal muscle.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Amplitude of the voltage‐induced Ca2+ transients in A/J and in A/W fibres with and without transfection
A and B, representative line‐scan confocal images of voltage‐induced Ca2+ transients (Rhod‐2 fluorescence) in A/W (A) and A/J (B) FBD fibres. Bars, 100 μm (vertical) and 250 ms (horizontal). C, corresponding profiles of voltage‐induced Ca2+ transients from the images A and B presented as (F max − F o)/F o. Black line, A/W; grey line, A/J. D, averaged amplitude of voltage‐induced Ca2+ transients in A/W and A/J fibres, presented as (F max − F o)/F o. Number of experiments is in white; * P < 0.001 compared to A/W. E and F, representative x–y confocal fluorescence images of A/J FBD fibres after transfection with Venus (E) or V‐Dysf (F). G, representative profiles of voltage‐induced Ca2+ transients from fibre areas transfected with V‐Dysf (black line) or non‐transfected (grey line). The voltage‐induced Ca2+ transients are normalized to F max in the area transfected with V‐Dysf. H, averaged amplitude of voltage‐induced Ca2+ transients in A/W and A/J fibres presented as (F max − F o)/F o. Number of experiments is in white; * P < 0.05 compared to V‐Dysf; bars, 10 μm. [Color figure can be viewed at wileyonlinelibrary.com]
Figure 2
Figure 2. Effects of Ca2+ channel inhibitors on voltage‐induced Ca2+ transients in A/W and A/J fibres
A, effects of diltiazem on voltage‐induced Ca2+ transients in A/W (black circles) and A/J (grey circles) FDB fibres. B, effects of diltiazem on voltage‐induced Ca2+ transients in A/J (grey circles) fibres and A/J muscle fibres transfected with wild‐type dysferlin (black open circles). C–F, dose‐dependent effects of verapamil (C), nifedipine (D), dantrolene (E) and tetracaine (F) on voltage‐induced Ca2+ transients in A/W (black circles) and A/J (grey circles) fibres. Number of experiments are given for corresponding colour; * P < 0.05 to corresponding value at the same concentration.
Figure 3
Figure 3. Effect of osmotic shock on Ca2+ transients in FBD fibres
A, C and E, representative line‐scan confocal images of voltage‐induced Ca2+ transients in A/W (A) and A/J (C) FBD fibres and A/J fibres transfected with V‐Dysf (E) before and 5 min after OSI. Distribution of V‐Dysf, introduced by electroporation and seen as Venus fluorescence, is shown on x–y images located on the right of panel E. B and D, corresponding profiles of voltage‐induced Ca2+ transients from the images presented in A and C for pre‐OSI (black line) and 5 min after OSI (grey line). Transients are normalized to F max for pre‐OSI conditions. F, averaged data for recovery of Ca2+ transients in FBD fibres under the different conditions used. Number of experiments in white; * P < 0.005 compared to A/W; bars, 100 μm (vertical) and 250 ms (horizontal).
Figure 4
Figure 4. Effects of pharmacological agents on recovery of voltage‐induced Ca2+ transients in A/J fibres after OSI
A, averaged data for recovery of Ca2+ transients in FBD fibres in the presence of 10 μm diltiazem (Dilt.), 10 μm verapamil (Verap.) or 5 μm nifedipine (Nifed). B, averaged data for recovery of Ca2+ transients after OSI in FBD fibres in the presence of 10 μm dantrolene (Dantr.), 1 μm tetracaine (Tetrac.) or 10 μm S107. Number of experiments is shown in white; * P < 0.05, compared to A/J. The two bars to the left duplicate those in A. C, averaged data for recovery of voltage‐induced Ca2+ transients during wash‐out of 10 μm tetracaine for A/W (no OSI; black circles) and A/J (no OSI; grey circles) fibres, and for A/J fibres after OSI (open circles). Data points are means of 6–27 independent experiments.
Figure 5
Figure 5. Effect of Ca2+‐free Tyrode solution on recovery of voltage‐induced Ca2+ transients from OSI in A/J fibres
A, representative line‐scan confocal images of the voltage‐induced Ca2+ transients in A/J FBD fibres before and after OSI in nominally Ca2+‐free Tyrode solution. B, corresponding profiles of transients from the images presented on A for pre‐OSI (black) and 5 min after OSI (grey) conditions. Voltage‐induced Ca2+ transients are normalized to F max for pre‐OSI conditions. Bars, 100 μm (vertical) and 250 ms (horizontal).
Figure 6
Figure 6. Ca2+ waves in A/J fibres after OSI
A, representative line‐scan confocal images of the voltage‐induced Ca2+ transients and Ca2+ waves in A/J fibres before and after OSI. Time (in minutes) after OSI is shown between panels. B, enlarged images of Ca2+ signals, reoriented with the initial time of stimulation at the upper left of each panel. Bars: left panel, 100 μm (vertical) and 250 ms (horizontal); right panel, 100 ms (vertical) and 25 μm (horizontal).
Figure 7
Figure 7. Spontaneous Ca2+ waves and sparks in A/J fibres after OSI
A, representative x–y scans of confocal images of spontaneous Ca2+ wave in A/J fibres after OSI as a function of time (in seconds). Bar, 10 μm. B, line‐scan confocal images of the voltage‐induced Ca2+ transients, and voltage‐induced (yellow arrows) and spontaneous (white arrows) Ca2+ sparks and bursts (green arrows) visualized at 9 min after OSI. The arrowhead indicates a location at which sparks arise repeatedly. Bars, 20 μm (vertical) and 250 ms (horizontal). C, representative Ca2+ sparks and bursts shown at higher magnification at 15 min after OSI. On the right are plotted time‐dependent changes in [Ca2+], recorded by averaging a 2 μm line at sites indicated by arrows. Bars, 10 μm (vertical) and 300 ms (horizontal). [Color figure can be viewed at wileyonlinelibrary.com]
Figure 8
Figure 8. V‐Dysf suppresses the development of Ca2+ waves in A/J fibres after OSI
Representative line‐scan confocal images of the voltage‐induced Ca2+ transients and Ca2+ waves in A/J fibres showing regional expression of V‐Dysf before and 5 min after OSI. Distribution of V‐Dysf, seen as Venus fluorescence, is shown on x–y images to the right. Bars, 100 μm (vertical) and 250 ms (horizontal). [Color figure can be viewed at wileyonlinelibrary.com]
Figure 9
Figure 9. Evidence against proteolysis in A/J fibres
A, representative line‐scan confocal images of the voltage‐induced Ca2+ transients and Ca2+ waves before and 5 min after OSI in A/J fibres pretreated for 1 h with 50 μm calpeptin. B, averaged data for recovery of Ca2+ transients in A/J FBD fibres pretreated and not pretreated with 50 μm calpeptin in comparison to A/W FBD fibres. Number of experiments is shown in white; * P < 0.005 compared to A/W. Bars, 100 μm (vertical) and 250 ms (horizontal). C, representative SDS‐PAGE shows amount of junctophilins 1 or 2 (JPH1 or JPH2) in A/J and A/W muscle fibres. Molecular mass markers, in kDa, are indicated. Glyceraldehyde phosphate dehydrogenase is the loading control, at 36 kDa.

References

    1. Aksentsev SL, Rakovich AA, Okoon IM, Konev SV, Orlov SN & Kravtsov GM (1983). Effect of tetracaine on veratrine‐mediated influx of sodium into rat brain synaptosomes. Pflugers Arch 397, 135–140. - PubMed
    1. Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Umanskaya A, Xie W, Shiomi T, Zalk R, Lacampagne A & Marks AR (2011). Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab 14, 196–207. - PMC - PubMed
    1. Andersson DC, Meli AC, Reiken S, Betzenhauser MJ, Umanskaya A, Shiomi T, D'Armiento J & Marks AR (2012). Leaky ryanodine receptors in β‐sarcoglycan deficient mice: a potential common defect in muscular dystrophy. Skelet Muscle 2, 9. - PMC - PubMed
    1. Bannister RA (2016). Bridging the myoplasmic gap II: more recent advances in skeletal muscle excitation‐contraction coupling. J Exp Biol 219, 175–182. - PubMed
    1. Bansal D & Campbell KP (2004). Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 14, 206–213. - PubMed

Publication types

MeSH terms